PL2872126T3 - Plaster farmaceutyczny do przezskórnego podawania tapentadolu - Google Patents
Plaster farmaceutyczny do przezskórnego podawania tapentadoluInfo
- Publication number
- PL2872126T3 PL2872126T3 PL13737149T PL13737149T PL2872126T3 PL 2872126 T3 PL2872126 T3 PL 2872126T3 PL 13737149 T PL13737149 T PL 13737149T PL 13737149 T PL13737149 T PL 13737149T PL 2872126 T3 PL2872126 T3 PL 2872126T3
- Authority
- PL
- Poland
- Prior art keywords
- tapentadol
- transdermal administration
- pharmaceutical patch
- patch
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261671975P | 2012-07-16 | 2012-07-16 | |
EP12005221 | 2012-07-16 | ||
PCT/EP2013/002096 WO2014012653A1 (en) | 2012-07-16 | 2013-07-15 | Pharmaceutical patch for transdermal administration of tapentadol |
EP13737149.8A EP2872126B1 (en) | 2012-07-16 | 2013-07-15 | Pharmaceutical patch for transdermal administration of tapentadol |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2872126T3 true PL2872126T3 (pl) | 2018-06-29 |
Family
ID=49948307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13737149T PL2872126T3 (pl) | 2012-07-16 | 2013-07-15 | Plaster farmaceutyczny do przezskórnego podawania tapentadolu |
Country Status (6)
Country | Link |
---|---|
US (2) | US20150148759A1 (pl) |
EP (1) | EP2872126B1 (pl) |
ES (1) | ES2661911T3 (pl) |
HU (1) | HUE035512T2 (pl) |
PL (1) | PL2872126T3 (pl) |
WO (1) | WO2014012653A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3169318B1 (en) | 2014-07-18 | 2020-04-01 | Buzzz Pharmaceuticals Limited | Abuse deterrent opiod/opiod-antagonist transdermal patch |
US9962349B2 (en) | 2014-10-17 | 2018-05-08 | Fidia Farmaceutici S.P.A. | Dermal therapeutic system with high adhesivity |
MX2020011269A (es) * | 2018-04-25 | 2020-12-11 | Shinkei Therapeutics Llc | Dispositivo de administración transdérmica de tetrabenazina. |
US11454003B2 (en) | 2018-09-10 | 2022-09-27 | Artemis Intelligent Power Limited | Apparatus with hydraulic machine controller |
US20220241218A1 (en) * | 2019-04-17 | 2022-08-04 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4145511A (en) * | 1977-09-01 | 1979-03-20 | The B. F. Goodrich Company | Hydroxyl-containing liquid polymers and pressure-sensitive adhesives and laminates prepared therefrom |
DE69009946T2 (de) * | 1989-12-04 | 1994-11-03 | Searle & Co | System zur transdermalen Albuterol Applikation. |
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
US5948433A (en) * | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
DE102005011517A1 (de) * | 2005-03-10 | 2006-09-21 | Grünenthal GmbH | Transdermales therapeutisches System zur Verabreichung von Analgetika |
EP1928924B1 (en) * | 2005-09-23 | 2011-05-18 | National Starch and Chemical Investment Holding Corporation | Acrylic polymer-based adhesives |
PE20110390A1 (es) | 2008-10-30 | 2011-07-09 | Gruenenthal Chemie | Composicion de tapentadol y un antagonista opioide |
US20110244022A1 (en) | 2010-03-30 | 2011-10-06 | Phosphagenics Limited | Transdermal delivery patch |
-
2013
- 2013-07-15 PL PL13737149T patent/PL2872126T3/pl unknown
- 2013-07-15 EP EP13737149.8A patent/EP2872126B1/en not_active Not-in-force
- 2013-07-15 ES ES13737149.8T patent/ES2661911T3/es active Active
- 2013-07-15 WO PCT/EP2013/002096 patent/WO2014012653A1/en active Application Filing
- 2013-07-15 HU HUE13737149A patent/HUE035512T2/en unknown
-
2015
- 2015-01-15 US US14/597,789 patent/US20150148759A1/en not_active Abandoned
-
2017
- 2017-01-19 US US15/409,929 patent/US20170128388A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2661911T3 (es) | 2018-04-04 |
EP2872126A1 (en) | 2015-05-20 |
HUE035512T2 (en) | 2018-05-02 |
US20150148759A1 (en) | 2015-05-28 |
US20170128388A1 (en) | 2017-05-11 |
WO2014012653A1 (en) | 2014-01-23 |
EP2872126B1 (en) | 2017-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
ZA201502352B (en) | Liposomal drug delivery system | |
EP2680918A4 (en) | TRANSDERMAL STAMP CONTAINING MICROARRAYS | |
EP2897598A4 (en) | TRANSDERMIC DRUG DELIVERY DEVICE | |
ZA201307862B (en) | Controlled release pharmaceutical dosage forms | |
HK1204564A1 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
PL2616133T3 (pl) | Aparaty do podawania leków przez skórę | |
HK1205146A1 (en) | Pharmaceutical formulation | |
IL236465B (en) | Pharmaceutical composition for delayed release of active substances | |
ZA201405797B (en) | Pharmaceutical dosage form | |
AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
PL2872126T3 (pl) | Plaster farmaceutyczny do przezskórnego podawania tapentadolu | |
HK1205683A1 (en) | Pharmaceutical formulation having improved stability | |
EP2898912A4 (en) | INSTRUMENT FOR MEDICINE ADMINISTRATION | |
IL227651A0 (en) | Pharmaceutical formulations for local introduction containing 220b | |
HK1206269A1 (en) | Pharmaceutical formulation comprising bendamustine | |
EP2851074A4 (en) | ANALGETIC PHARMACEUTICAL COMPOSITION | |
ZA201306823B (en) | Excipient system for topical delivery of pharmaceutical agents | |
EP2873422A4 (en) | PHARMACEUTICAL PREPARATION FOR INJECTION | |
ZA201502354B (en) | Pharmaceutical dosage form | |
GB201213729D0 (en) | Manufacture of insoluble drugs | |
GB201109291D0 (en) | Muco-adhesive tablet for systemic administration of insulin | |
GB201301179D0 (en) | Pharmaceutical composition comprising opioid analgesic |